• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮CT引导下骨病变活检以确诊乳腺癌患者的骨转移

Percutaneous CT-Guided Bone Lesion Biopsy for Confirmation of Bone Metastases in Patients with Breast Cancer.

作者信息

Kovacevic Lucija, Cavka Mislav, Marusic Zlatko, Kresic Elvira, Stajduhar Andrija, Grbanovic Lora, Dumic-Cule Ivo, Prutki Maja

机构信息

Clinical Department of Diagnostic and Interventional Radiology, University Hospital Center Zagreb School of Medicine, University of Zagreb, Kispaticeva 12, 10000 Zagreb, Croatia.

Clinical Department of Pathology and Cytology, University Hospital Centre Zagreb, Kispaticeva 12, 10000 Zagreb, Croatia.

出版信息

Diagnostics (Basel). 2022 Aug 29;12(9):2094. doi: 10.3390/diagnostics12092094.

DOI:10.3390/diagnostics12092094
PMID:36140495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9497624/
Abstract

We aimed to determine diagnostic accuracy of CT-guided bone lesion biopsy for the confirmation of bone metastases in patients with breast cancer and assessment of hormone receptor status in metastatic tissue. A total of 56 female patients with breast cancer that underwent CT-guided biopsy of suspected bone metastasis were enrolled in this retrospective study. Three different techniques were employed to obtain samples from various sites of skeleton. Collectively, 11 true negative and 3 false negative findings were revealed. The sensitivity of CT-guided biopsy for diagnosing bone metastases was 93.6%, specificity was 100% and accuracy was 94.8%. Discordance in progesterone receptor status and complete concordance in estrogen receptor status was observed. Based on our single-center experience, bone metastasis biopsy should be routinely performed in patients with breast cancer and suspicious bone lesions, due to the impact on further treatment.

摘要

我们旨在确定CT引导下骨病变活检对乳腺癌患者骨转移的确诊及转移组织中激素受体状态评估的诊断准确性。本项回顾性研究纳入了56例接受CT引导下疑似骨转移活检的女性乳腺癌患者。采用三种不同技术从骨骼的不同部位获取样本。总共发现11例假阴性和3例假阳性结果。CT引导下活检诊断骨转移瘤的灵敏度为93.6%,特异度为100%,准确度为94.8%。观察到孕激素受体状态存在不一致,而雌激素受体状态完全一致。基于我们单中心的经验,由于对进一步治疗有影响,乳腺癌合并可疑骨病变的患者应常规进行骨转移活检。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea97/9497624/8fa5686f345b/diagnostics-12-02094-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea97/9497624/e8047f101fe4/diagnostics-12-02094-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea97/9497624/2e8d3254015c/diagnostics-12-02094-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea97/9497624/b51bfb151437/diagnostics-12-02094-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea97/9497624/e81427d47c6c/diagnostics-12-02094-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea97/9497624/8fa5686f345b/diagnostics-12-02094-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea97/9497624/e8047f101fe4/diagnostics-12-02094-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea97/9497624/2e8d3254015c/diagnostics-12-02094-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea97/9497624/b51bfb151437/diagnostics-12-02094-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea97/9497624/e81427d47c6c/diagnostics-12-02094-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea97/9497624/8fa5686f345b/diagnostics-12-02094-g005.jpg

相似文献

1
Percutaneous CT-Guided Bone Lesion Biopsy for Confirmation of Bone Metastases in Patients with Breast Cancer.经皮CT引导下骨病变活检以确诊乳腺癌患者的骨转移
Diagnostics (Basel). 2022 Aug 29;12(9):2094. doi: 10.3390/diagnostics12092094.
2
Acquisition of metastatic tissue from patients with bone metastases from breast cancer.从患有乳腺癌骨转移的患者中获取转移性组织。
Breast Cancer Res Treat. 2011 Oct;129(3):761-5. doi: 10.1007/s10549-010-1264-6. Epub 2010 Nov 27.
3
Is it sufficient to evaluate metastatic bone involvement in breast cancer using SPECT/CT? A new approach of SPECT/CT-guided targeted bone marrow biopsy.仅使用 SPECT/CT 评估乳腺癌的骨转移是否足够?一种 SPECT/CT 引导下的靶向骨髓活检新方法。
BMC Cancer. 2022 Jun 4;22(1):614. doi: 10.1186/s12885-022-09702-1.
4
Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer.骨转移与原发性乳腺癌相比,激素受体和人表皮生长因子受体 2 状态不一致。
Acta Oncol. 2013 Nov;52(8):1649-56. doi: 10.3109/0284186X.2012.754990. Epub 2013 Jan 17.
5
Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives.乳腺癌患者转移灶的活检确认:临床影响和未来展望。
Breast Cancer Res. 2014;16(2):205. doi: 10.1186/bcr3630.
6
F-FDG PET/CT-Guided Real-Time Automated Robotic Arm-Assisted Needle Navigation for Percutaneous Biopsy of Hypermetabolic Bone Lesions: Diagnostic Performance and Clinical Impact.18F-FDG PET/CT 引导实时自动机械臂辅助经皮骨病变活检:诊断性能和临床影响。
AJR Am J Roentgenol. 2019 Jan;212(1):W10-W18. doi: 10.2214/AJR.18.19698. Epub 2018 Nov 1.
7
PET/CT-guided percutaneous biopsy of FDG-avid metastatic bone lesions in patients with advanced lung cancer: a safe and effective technique.PET/CT引导下对晚期肺癌患者FDG摄取阳性的转移性骨病变进行经皮活检:一种安全有效的技术。
Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):25-32. doi: 10.1007/s00259-016-3455-9. Epub 2016 Jul 22.
8
The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.99mTc-替曲膦单光子发射计算机断层扫描在检测肺外原发性肿瘤肺转移中的应用价值。
Radiol Med. 2004 Jan-Feb;107(1-2):113-27.
9
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
10
Conical utility of CT-guided biopsies in orthopaedic oncology.CT引导下活检在骨肿瘤学中的锥形效用。
Iowa Orthop J. 2010;30:76-9.

引用本文的文献

1
Prediction of bone oligometastases in breast cancer using models based on deep learning radiomics of PET/CT imaging.使用基于PET/CT成像深度学习影像组学的模型预测乳腺癌骨寡转移。
Front Oncol. 2025 Aug 21;15:1621677. doi: 10.3389/fonc.2025.1621677. eCollection 2025.
2
CT Texture Analysis in Breast Cancer Patients Undergoing CT-Guided Bone Biopsy: Correlations With Histopathology.接受CT引导下骨活检的乳腺癌患者的CT纹理分析:与组织病理学的相关性
Breast Cancer (Auckl). 2025 Jan 29;19:11782234241305886. doi: 10.1177/11782234241305886. eCollection 2025.
3
Biopsy of bone tumors: a literature review.

本文引用的文献

1
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer.欧洲肿瘤内科学会转移性乳腺癌患者诊断、分期及治疗临床实践指南
Ann Oncol. 2021 Dec;32(12):1475-1495. doi: 10.1016/j.annonc.2021.09.019. Epub 2021 Oct 19.
2
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.Sacituzumab Govitecan 治疗转移性三阴性乳腺癌。
N Engl J Med. 2021 Apr 22;384(16):1529-1541. doi: 10.1056/NEJMoa2028485.
3
Sympathetic activity in breast cancer and metastasis: partners in crime.
骨肿瘤活检:文献综述
Rev Assoc Med Bras (1992). 2024 Jun 7;70(suppl 1):e2024S131. doi: 10.1590/1806-9282.2024S131. eCollection 2024.
4
Complications of Percutaneous Vertebroplasty: A Pictorial Review.经皮椎体成形术的并发症:影像学综述。
Medicina (Kaunas). 2023 Aug 25;59(9):1536. doi: 10.3390/medicina59091536.
5
Percutaneous CT-Guided Bone Biopsies: Indications, Feasibility and Diagnostic Yield in the Different Skeletal Sites-From the Skull to the Toe.经皮CT引导下骨活检:从颅骨到脚趾不同骨骼部位的适应证、可行性及诊断率
Diagnostics (Basel). 2023 Jul 12;13(14):2350. doi: 10.3390/diagnostics13142350.
6
Ultrasound-Guided Percutaneous Bone Biopsy: Feasibility, Diagnostic Yield and Technical Notes.超声引导下经皮骨活检:可行性、诊断率及技术要点
Diagnostics (Basel). 2023 May 17;13(10):1773. doi: 10.3390/diagnostics13101773.
乳腺癌与转移中的交感神经活动:罪恶伙伴。
Bone Res. 2021 Feb 5;9(1):9. doi: 10.1038/s41413-021-00137-1.
4
The lingering mysteries of metastatic recurrence in breast cancer.乳腺癌转移复发的未解之谜。
Br J Cancer. 2021 Jan;124(1):13-26. doi: 10.1038/s41416-020-01161-4. Epub 2020 Nov 26.
5
Breast Cancer Statistics in the European Union: Incidence and Survival across European Countries.欧盟乳腺癌统计数据:欧洲各国的发病率与生存率
Breast Care (Basel). 2019 Dec;14(6):344-353. doi: 10.1159/000503219. Epub 2019 Oct 8.
6
Decalcification of Breast Cancer Bone Metastases With EDTA Does Not Affect ER, PR, and HER2 Results.EDTA 脱钙处理乳腺癌骨转移不影响 ER、PR 和 HER2 检测结果。
Am J Surg Pathol. 2019 Oct;43(10):1355-1360. doi: 10.1097/PAS.0000000000001321.
7
Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.转移性乳腺癌患者锁骨上转移灶的特征及转归:原发灶与转移灶受体状态的不一致性
Anticancer Res. 2018 Oct;38(10):6023-6026. doi: 10.21873/anticanres.12952.
8
Whole-Body MRI with Diffusion-Weighted Imaging in Bone Metastases: A Narrative Review.全身磁共振成像联合扩散加权成像在骨转移瘤中的应用:一篇叙述性综述
Diagnostics (Basel). 2018 Jul 9;8(3):45. doi: 10.3390/diagnostics8030045.
9
Percutaneous, Imaging-Guided Biopsy of Bone Metastases.经皮影像引导下骨转移瘤活检
Diagnostics (Basel). 2018 Apr 18;8(2):25. doi: 10.3390/diagnostics8020025.
10
Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990-2010.随时间推移的新发转移性乳腺癌与复发性转移性乳腺癌的差异表现与生存:1990-2010 年。
Breast Cancer Res Treat. 2018 Jan;167(2):579-590. doi: 10.1007/s10549-017-4529-5. Epub 2017 Oct 16.